Two IBEC researchers receive a Beatriu de Pinós fellowship
Elisabeth Engel
Group leader
3D printed hydrogels for cancer immunotherapy T-cell growth
The new 3D hydrogels provide high rates of cell proliferation, as they mimic lymph nodes, where T-cells reproduce in vivo. A new project, led by researchers from ICMAB and IBEC, and with the collaboration of VHIO and UIC, wants to transfer this technology to hospitals.
Cancer immunotherapy is based on using and strengthening the patient’s own immune system to recognize and fight tumor cells, without damaging healthy tissues.
Elisabeth Engel at Santander Pioneros: it’s time to support science
Three protagonists of the medical research field in Spain debated in a new edition of the “Pioneros Santander” forum, organized virtually by El País Retina. Elisabeth Engel, group leader of Biomaterials for regenerative therapies at IBEC, Rocío Arroyo, CEO of Amadix and Eduardo Jorgensen, of Medicsen, also CEO, agreed to celebrate the greatest interest in their work area, the intersection between science, technology and health, but at the same time they were cautious: there are no shortcuts in research, neither before Covid-19 nor after.
Three protagonists of the medical research field in Spain debated in a new edition of the “Pioneros Santander” forum, organized virtually by El País Retina. Elisabeth Engel, group leader of Biomaterials for regenerative therapies at IBEC, Rocío Arroyo, CEO of Amadix and Eduardo Jorgensen, of Medicsen, also CEO, agreed to celebrate the greatest interest in their work area, the intersection between science, technology and health, but at the same time they were cautious: there are no shortcuts in research, neither before Covid-19 nor after.IBEC leads three new European projects
Bioengineering is a core discipline for the medicine of the future, and Europe knows that. Proof of this is that the European Union (EU) has granted during the last months the coordination of three European projects to the Institute for Bioengineering of Catalonia (IBEC) to continue combining medicine, science and technology with the aim of improving people’s health.
Bioengineering is a core discipline for the medicine of the future, and Europe knows that. Proof of this is that the European Union (EU) has granted during the last months the coordination of three European projects to the Institute for Bioengineering of Catalonia (IBEC) to continue combining medicine, science and technology with the aim of improving people’s health. The first one is the BRIGHTER project that is led by Professor Elena Martínez, the head of the ‘Biomimetic Systems for Cell Engineering’ group. The EU has contributed to this initiative that will be used by the consortium partners to develop an innovative high resolution 3D bioprinting technology able to fabricate 3D cell culture substrates which could be useful to produce artificial organs in the future.
Senior Researcher at the Biomaterials for Regenerative Therapies Group
Application Deadline: 27/05/2020
Ref: SR-EE
The Biomaterials for Regenerative Therapies group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Senior Researcher to work on the development of new platforms for skin regeneration. The contract will be within the framework of nAngioderm, an Euronanomed project, whose objective is to develop devices based on nanotechnology and drug delivery tools able to address the healing of acute and chronic wounds.
IBEC joins the BASE3D community to contribute to the future of 3D printing
The Institute for Bioengineering of Catalonia (IBEC) will contribute its extensive experience in 3D printing and bioprinting to the BASE 3D community, an entity that brings together research centers and companies from all over Catalonia with the aim of promoting R+D+i in the field of printing 3D.
The Institute for Bioengineering of Catalonia (IBEC) will contribute its extensive experience in 3D printing and bioprinting to the BASE 3D community, an entity that brings together research centers and companies from all over Catalonia with the aim of promoting R+D+i in the field of printing 3D.The groups led by Josep Samitier, Elisabeth Engel, Núria Montserrat and Javier Ramón at IBEC are joining the BASE3D project.
Elisabeth Engel at “El Método” podcast
Second release of our monthly collaboration with Luís Quevedo at “El Método” podcast. It’s Elisabeth Engel’s turn, principal investigator of the “Biomaterials for regenerative therapies” at IBEC talking about biomaterials, 3D bioprinting, personalised medicine among other things.
IBEC coordinates a project to promote skin regeneration using nanoparticles and 3D printing
Elisabeth Engel, principal investigator of the “Biomaterials for regenerative therapies” group at IBEC will coordinate a three-year project with the aim of boosting skin self-regeneration. This transnational European consortium composed of four more partners will develop the project over the next 3 years, including Dimitrios Zeugolis (University of Ioannina, Greece), Joan Pere Barret (Hospital Universitari Vall d’Hebron, Spain), Olivier Stephan (Université Grenoble-Alpes, France) and Denis Barbier (MicroLight 3D, France).
Elisabeth Engel, principal investigator of the “Biomaterials for regenerative therapies” group at IBEC will coordinate a three-year project with the aim of boosting skin self-regeneration. This transnational European consortium composed of four more partners will develop the project over the next 3 years, including Dimitrios Zeugolis (University of Ioannina, Greece), Joan Pere Barret (Hospital Universitari Vall d’Hebron, Spain), Olivier Stephan (Université Grenoble-Alpes, France) and Denis Barbier (MicroLight 3D, France). The project falls under the scope of EuroNanoMed3 programme, and the consortium will receive a total of 747.000 € through the corresponding national funding agencies of the countries involved. In particular, the “Agencia Estatal de Investigación” (Ministerio de Ciencia, Innovación y Universidades) will fund IBEC’s contribution with 190.000 €.
Elisabeth Engel en radio Euskadi
On the occasion of the annual meeting of the centres of excellence “Severo Ochoa and Maria de Maeztu” (SOMMa) at the 100xCiencia event, held in San Sebastián on November 22 and 23, Elisabeth Engel spoke on radio Euskadi about the intelligent devices they are developing in their laboratory. These bandages release nanoparticles containing calcium ions that are able to heal chronic lesions such as ulcers.
On the occasion of the annual meeting of the centres of excellence “Severo Ochoa and Maria de Maeztu” (SOMMa) at the 100xCiencia event, held in San Sebastián on November 22 and 23, Elisabeth Engel spoke on radio Euskadi about the intelligent devices they are developing in their laboratory. These bandages release nanoparticles containing calcium ions that are able to heal chronic lesions such as ulcers.“Prueban prótesis para huesos impresos en 3D capaces de regenerarse”
Pronto magazine reported on IBEC’s 3D bioprinting capabilities and, in particular, the collaboration of the company AVINENT S.L. and the institute to carry out a research project to print personalized bone structures using 3D technology.